Indicator Explainer
SARS-CoV-2 RNA
Molecular detection of SARS-CoV-2 in respiratory specimens.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Used for acute diagnosis in symptomatic patients, admission screening in care settings, and public-health surveillance programs.
Reading results
Result quality depends on specimen timing and collection site relative to symptom onset; Ct ranges are not comparable between assays and should not be read as infectivity measures without a laboratory-specific policy.
Questions to ask a professional
- Which variants does the assay documentation list as confirmed?
- Is this run qualitative or reported with Ct values?
Related Tests
Tests that measure or involve this indicator.
References
- [Application of the PCR number of cycle threshold value (Ct) in COVID-19]. — Semergen, 2021 (PMID doi: 10.1016/j.semerg.2021.05.003)
- Considerations regarding Interpretation of Positive SARS-CoV-2 Molecular Results with Late Cycle Threshold Values. — Journal of clinical microbiology, 2022 (PMID doi: 10.1128/jcm.00501-22)
- Persistent SARS-CoV-2 RNA Positivity in a Chronic Lymphocytic Leukaemia Patient for 127 Days After Disease Onset: A Case Report. — Respirol Case Rep, 2026-10-05 (PMID 42840498; literature)
- Infection of urban rodents by SARS-CoV-2 in COVID-19 healthcare facilities in Brazzaville, Republic of the Congo. — One Health Outlook, 2026-09-29 (PMID 42806424; literature)
- Evaluation of wastewater SARS-CoV-2 surveillance for monitoring COVID-19 trends and early warning in Sweden, 2023-2024. — PLoS One, 2026-09-21 (PMID 42766597; literature)
- SARS-CoV-2 Exposure Elicits a Strong Mucosal Antibody Response That May Facilitate Quicker Mucosal Viral Clearance. — Viruses, 2026-09-17 (PMID 42797865; literature)
- An ATP-Driven N Protein-DDX21 Molecular Switch Dynamically Controls SARS-CoV-2 RNA G-Quadruplex Heterogeneity. — Adv Sci (Weinh), 2026-09-16 (PMID 42750138; literature)
- Potent halt of SARS-CoV-2 replication using clitocine-induced emergent-viral-RNA editing and disruption. — RSC Adv, 2026-09-15 (PMID 42746313; literature)
- Remdesivir maintains antiviral potency against clinically relevant SARS-CoV-2 Nsp12 substitutions. — Antiviral Res, 2026-09-14 (PMID 42735890; literature)
- Circulating cholesterol fuels SARS-CoV-2 replication via ORF3a. — EMBO Rep, 2026-09-11 (PMID 42728375; literature)
- Wastewater surveillance for SARS-CoV-2 and influenza A: A complementary tool for monitoring community transmission and variant dynamics. — J Environ Qual, 2026-09-01 (PMID 42765372; literature)
- Long-term wastewater surveillance of SARS-CoV-2: a 5.5-year study reveals correlation with public health indicators and early warning potential during and after the pandemic. — Front Microbiol, 2026-08-18 (PMID 42682696; literature)
- Circulating SARS-CoV-2 RNA detection in acute COVID-19 disease and Post-COVID Condition. — Clin Microbiol Infect, 2026-10-12 (PMID 42863757; literature)
- Gapmers targeting conserved SARS-CoV-2 single-stranded regions reduce viral load and reshape inflammatory macrophage responses. — iScience, 2026-09-28 (PMID 42857698; literature)
- Comparison of RT-ddPCR and RT-qPCR for detection and quantification of SARS-CoV-2 RNA in archived skilled nursing facility wastewater. — J Microbiol Methods, 2026-10-17 (PMID 42892440; literature)
- Early functional maturation of anti-Spike antibodies predicts efficient SARS-CoV-2 RNA clearance. — Front Immunol, 2026-10-02 (PMID 42890211; literature)